[Broncholytic effect of pencardin in chronic bronchial asthma].
D000328:Adult; D000368:Aged; D000628:Aminophylline / Q000008:administration & dosage / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001980:Bronchi / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010417:Pentaerythritol Tetranitrate / Q000008:administration & dosage; D010634:Phenobarbital / Q000008:administration & dosage / Q000627:therapeutic use*; D011409:Propylene Glycols / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D004338:Drug Combinations; D011409:Propylene Glycols; D010417:Pentaerythritol Tetranitrate; D000628:Aminophylline; C030339:Pencardin; D010208:Papaverine; D010634:Phenobarbital
Ocena działania broncholitycznego preparatu pencardin u chorych z przewlekłym zapaleniem oskrzeli.